NCT00109525

Brief Summary

This observational study evaluated the performance of new lab tests in detecting candida species fungal infections in extremely low birth weight (ELBW) infants quickly and accurately. 19 NICHD Neonatal Research Network sites enrolled 1,500 infants with birth weights ≤1,000g; 100 of these infants later tested positive for candidiasis. Blood, urine, and lumbar puncture samples were collected whenever other specimens were obtained from participants for cultures. These samples are being tested using the new methods and compared with standard culture results. Surviving study subjects completed a neurodevelopmental evaluation at 18-22 months corrected age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2004

Longer than P75 for all trials

Geographic Reach
1 country

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 29, 2005

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2007

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

3.3 years

First QC Date

April 28, 2005

Last Update Submit

March 20, 2019

Conditions

Keywords

NICHD Neonatal Research NetworkFungal InfectionMycosisExtremely Low Birth Weight (ELBW)PrematurityClinical JudgementPolymerase chain reaction (PCR) testingBeta-glucan assayMass SpectrometryLumbar puncture

Outcome Measures

Primary Outcomes (2)

  • Probability of invasive candidiasis based on new assay results

    Until discharge

  • Determine test performance of clinical predictive model

    Until discharge

Secondary Outcomes (14)

  • Determine test performance (sensitivity and specificity) of polymerase chain reaction (PCR) testing

    Until discharge

  • Determine test performance of Beta-glucan assay

    Until discharge

  • Determine test performance of Gas Chromatography Mass Spectrometry for D-arabinitol of blood samples

    Until discharge

  • Determine test performance of Gas Chromatography Mass Spectrometry for D-arabinitol of urine samples

    Until discharge

  • Determine test performance of the blood culture

    Until discharge

  • +9 more secondary outcomes

Eligibility Criteria

Age3 Days - 120 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants with birth weights ≤1,000 grams

You may qualify if:

  • Infants born ≤1,000g birth weight
  • Infants \>72 hours old and less than 120 days old

You may not qualify if:

  • Prior positive blood culture for Candida
  • Evidence of congenital candidiasis
  • Parents/legal guardians refuse consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

Stanford University

Palo Alto, California, 94304, United States

Location

University of California at San Diego

San Diego, California, 92103-8774, United States

Location

Yale University

New Haven, Connecticut, 06504, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

Emory University

Atlanta, Georgia, 30303, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

Wayne State University

Detroit, Michigan, 48201, United States

Location

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

Wake Forest University

Charlotte, North Carolina, 27157, United States

Location

RTI International

Durham, North Carolina, 27705, United States

Location

Duke University

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Medical Center

Cincinnati, Ohio, 45267, United States

Location

Case Western Reserve University, Rainbow Babies and Children's Hospital

Cleveland, Ohio, 44106, United States

Location

Brown University, Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

University of Texas Southwestern Medical Center at Dallas

Dallas, Texas, 75235, United States

Location

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (5)

  • Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, Shankaran S, Higgins RD, Auten KJ, Miller NA, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Chapman RL, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010 Oct;126(4):e865-73. doi: 10.1542/peds.2009-3412. Epub 2010 Sep 27.

  • Adams-Chapman I, Bann CM, Das A, Goldberg RN, Stoll BJ, Walsh MC, Sanchez PJ, Higgins RD, Shankaran S, Watterberg KL, Duara S, Miller NA, Heyne RJ, Peralta-Carcelen M, Goldstein RF, Steichen JJ, Bauer CR, Hintz SR, Evans PW, Acarregui MJ, Myers GJ, Vohr BR, Wilson-Costello DE, Pappas A, Vaucher YE, Ehrenkranz RA, McGowan EC, Dillard RG, Fuller J, Benjamin DK Jr; Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013 Oct;163(4):961-7.e3. doi: 10.1016/j.jpeds.2013.04.034. Epub 2013 May 30.

  • Bliss JM, Wong AY, Bhak G, Laforce-Nesbitt SS, Taylor S, Tan S, Stoll BJ, Higgins RD, Shankaran S, Benjamin DK Jr; Candida Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Candida virulence properties and adverse clinical outcomes in neonatal candidiasis. J Pediatr. 2012 Sep;161(3):441-447.e2. doi: 10.1016/j.jpeds.2012.02.051. Epub 2012 Apr 14.

  • Greenberg RG, Benjamin DK Jr, Gantz MG, Cotten CM, Stoll BJ, Walsh MC, Sanchez PJ, Shankaran S, Das A, Higgins RD, Miller NA, Auten KJ, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Ehrenkranz RA, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN, Smith PB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012 Aug;161(2):264-9.e2. doi: 10.1016/j.jpeds.2012.01.053. Epub 2012 Mar 15.

  • Wynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, Stoll BJ, Shankaran S, Walsh MC, Auten KJ, Miller NA, Sanchez PJ, Higgins RD, Cotten CM, Smith PB, Benjamin DK Jr; NICHD Neonatal Research Network. Outcomes following candiduria in extremely low birth weight infants. Clin Infect Dis. 2012 Feb 1;54(3):331-9. doi: 10.1093/cid/cir800. Epub 2011 Dec 5.

Related Links

MeSH Terms

Conditions

InfectionsTorulopsisCandidiasisPremature BirthMycosesPathologic Complete Response

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDisease ProgressionDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Abbot R. Laptook, MD

    Brown University, Women & Infants Hospital of Rhode Island

    PRINCIPAL INVESTIGATOR
  • Michele C. Walsh, MD MS

    Case Western Reserve University, Rainbow Babies and Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Ronald N. Goldberg, MD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Barbara J. Stoll, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Brenda B. Poindexter, MD MS

    Indiana University

    PRINCIPAL INVESTIGATOR
  • Abhik Das, PhD

    RTI International

    PRINCIPAL INVESTIGATOR
  • Krisa P. Van Meurs, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Ivan D. Frantz III, MD

    Tufts Medical Center

    PRINCIPAL INVESTIGATOR
  • Waldemar A. Carlo, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Neil N. Finer, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Kurt Schibler, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
  • Edward F. Bell, MD

    University of Iowa

    PRINCIPAL INVESTIGATOR
  • Shahnaz Duara, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Kristi L. Watterberg, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR
  • Dale L. Phelps, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Kathleen A. Kennedy, MD MPH

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • Pablo J. Sanchez, MD

    University of Texas, Southwestern Medical Center at Dallas

    PRINCIPAL INVESTIGATOR
  • T. Michael O'Shea, MD MPH

    Wake Forest University

    PRINCIPAL INVESTIGATOR
  • Seetha Shankaran, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR
  • Richard A. Ehrenkranz, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2005

First Posted

April 29, 2005

Study Start

March 1, 2004

Primary Completion

July 1, 2007

Study Completion

December 1, 2009

Last Updated

March 22, 2019

Record last verified: 2019-03

Locations